Wegovy is an injectable weight loss medication containing semaglutide, a GLP-1 receptor agonist that mimics a hormone naturally produced in your intestines
Standard oral glutathione gets destroyed in your stomach before it ever reaches your bloodstream
Hydration strategies are critical, particularly for patients experiencing vomiting or diarrhea
Many insurance policies often do not include combined medications, particularly when they are prescribed for weight loss goals
By focusing on dietary choices, increasing physical activity, maintaining medication adherence, managing psychological factors, and seeking personalized support, we can optimize our weight loss journey
The cardiovascular outcomes trial SUSTAIN-6 demonstrated that semaglutide reduced the risk of major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease